These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2004-002181-38||WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF)||2011-07-19||bad-data|
|Not reported||2005-004080-28||Efficacy and Safety of Niaspan in South Asian Stroke Survivors: NIASTAR TRIAL (Niaspan: Indo-Asian Stroke patienT Atherosclerotic Regression trial)||2006-02-08||due-trials|
|Ongoing||2009-017176-25||Aspirin resistance and heart disease||not-yet-due|
|Reported results||2010-021257-39||Is it clinically effective to treat arm flexor spasticity, with Botulinum toxin – type A (BoNTA) and physiotherapy, as soon as signs of abnormal muscle activity are observed? (A phase II study)||2014-05-28||due-trials|
|Ongoing||2012-004988-42||REVISE-Diabesity: Randomisation to Endoluminal intestinal liner alone Versus with Incretin analogue in SustainEd Diabesity||not-yet-due|
|Reported results||2013-003107-19||Phase II clinical trial investigating the use of epigallocatechin-3-gallate (Veregen) in the treatment of vulval intraepithelial neoplasia||2019-01-07||due-trials|
|Completed, report not yet due||2013-004246-41||A phase III randomised study of folic acid supplementation in the management of menopausal symptoms in cancer survivors and healthy postmenopausal women||2020-03-19||not-yet-due|